TH dysregulation has been suggested to have a role in several retinal diseases including diabetic retinopathy and age-related macular degeneration (Nicolini et al. 2024), and further study may reveal new targets for therapeutics. This evidence concerns the gene TH and Abnormal retinal morphology.